Search clinical trials for: high risk prostate cancer
Total 111412 results
-
SOTIO a.s.Completed
-
Cedars-Sinai Medical CenterBristol-Myers SquibbTerminatedUrogenital Neoplasms | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Male | Prostatic Neoplasms | Prostatic Diseases | Genital Diseases, MaleUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterRadiation Therapy Oncology GroupCompletedProstate CancerUnited States
-
Lawson Health Research InstituteTerminated
-
Kantonsspital GraubuendenCompletedLymph Node Disease | Radiotherapy Side Effect | Prostatic Neoplasms BenignSwitzerland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Thomas E. AhleringNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Sunnybrook Health Sciences CentreUnknownCarcinoma of the ProstateCanada
-
Noah Hahn, M.D.Bristol-Myers SquibbTerminatedProstate CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)Completed
-
St. Olavs HospitalNorwegian University of Science and Technology; Norwegian Cancer SocietyCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Central Hospital, Nancy, FranceUnknown
-
Rabin Medical CenterUnknownLynch Syndrome | BRCA1 Syndrome | BRCA2 SyndromeIsrael
-
UNC Lineberger Comprehensive Cancer CenterSanofiCompleted
-
University of Michigan Rogel Cancer CenterNovartis PharmaceuticalsTerminatedProstate CancerUnited States
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science University; Portland...Completed
-
Focal Healthcare Inc.Unknown
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
AHS Cancer Control AlbertaUnknownHigh-risk Prostate CancerCanada
-
University Health Network, TorontoProstate Cancer CanadaCompleted
-
NovartisCompleted
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
RWTH Aachen UniversityTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
AHS Cancer Control AlbertaUnknown
-
CureVacTerminated
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Proton Collaborative GroupTerminatedProstate CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Precancerous ConditionUnited States
-
Wuerzburg University HospitalUniversitaire Ziekenhuizen KU LeuvenTerminatedProstate Cancer | Radical ProstatectomyGermany
-
Helsinki University Central HospitalUnknown
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
University of WaterlooGrand River Regional Cancer CentreCompleted
-
ImaginAb, Inc.WithdrawnProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Hospital de CrucesUnknown
-
AstraZenecaCompleted2 Years PSA Recurrence RateChina
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedProstate CancerUnited States
-
Centre Georges Francois LeclercTerminated
-
Benaroya Research InstituteGenentech, Inc.CompletedProstate CancerUnited States
-
European Organisation for Research and Treatment...Terminated
-
Cougar Biotechnology, Inc.CompletedProstate CancerUnited States
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
Beth Israel Deaconess Medical CenterWalter Reed Army Medical CenterCompletedProstate CancerUnited States
-
University of KansasCompleted